Describes the evolution of the company starting in the segment of clinical pathology laboratory business lab. U.S. tries Labs series of business models before running out of cash. The company urgently needs funding, as his supporters refused to put up the venture capital and more capital the bank and calls his credit. Discussed, as the CEO is ready to put its own funding and still believes in the future of the company. "Hide
by Michael J. Roberts, Robert F. Higgins Source: Harvard Business School 26 pages. Publication Date: February 4, 2002. Prod. #: 802163-PDF-ENG